ADARx Pharmaceuticals, Inc. (ADRX) stock
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$12.82−1.00 (-7.24%)
Close on Nov 18, 2026Market cap $1.38BP/E –Yield –
ADARx Pharmaceuticals shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
No shares outstanding figures for ADARx Pharmaceuticals
ADARx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?